Multicentric Cohort of Melanoma Patients in Ile de France Area
Melan-Cohort should constitute the first multicentric cohort with various objectives:
prognostic, therapeutic, cognitive and medico-economical studies on melanoma. Patients will
be recruited in all of the dermatology departments of APHP (dermatology departments from
AMBROISE PARE, Saint-Louis, BICHAT-Claude Bernard,Henri-Mondor, Cochin-Tarnier, and Tenon
hospitals). For all included patients, a standard file is filled comprising all
anatomy-clinical useful data and epidemiologic ones, including sun exposures. Blood is
harvested to collect DNA, RNA, serum, plasma at inclusion and at regular intervals and in
case of progressive disease. Procedures for sentinel lymph node biopsies have been
homogenized. An informed consent is obtained for each patient included in the cohort. A
steering committee meets on a regular basis, and genetics or pathology subgroups have been
constituted. An electronic CRF is available using the Intranet of APHP hospitals. Specimens
are stored using high quality standards.
Observational
Observational Model: Cohort, Time Perspective: Prospective
Overall survival (0-10 years) Disease free survival (0-10 years)
10 years
No
Philippe Saiag, MD
Principal Investigator
Assistance Publique - Hôpitaux de Paris
France: Ministry of Health
P020927
NCT00839410
September 2003
December 2018
Name | Location |
---|